Drug Shortage Report for 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION
| Report ID | 101629 |
| Drug Identification Number | 00828602 |
| Brand name | LIDOCAINE HCL 0.4% AND 5% DEXTROSE INJ |
| Common or Proper name | LIDOCAINE HCL 0.4% AND 5% DEXTROSE INJ |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE LIDOCAINE HYDROCHLORIDE |
| Strength(s) | 50MG 4MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 24 units/case |
| ATC code | C01BB |
| ATC description | ANTIARRHYTHMICS, CLASS I AND III |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2019-12-18 |
| Actual start date | 2019-12-18 |
| Estimated end date | 2020-01-27 |
| Actual end date | 2020-01-27 |
| Shortage status | Resolved |
| Updated date | 2020-01-28 |
| Company comments | Baxter product LIDOCAINE HYDROCHLORIDE 0.4% AND 5% DEXTROSE INJECTION (250 mL bags) is available as a substitute. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-01-28 | English | Compare |
| v4 | 2020-01-27 | French | Compare |
| v3 | 2020-01-27 | English | Compare |
| v2 | 2019-12-19 | French | Compare |
| v1 | 2019-12-19 | English | Compare |
Showing 1 to 5 of 5